---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-042468"
form_type: "8-K"
ticker: "BMEA"
cik: "0001840439"
company_name: "Biomea Fusion, Inc."
filed_at: "2025-02-28T23:59:59+00:00"
generated_at: "2026-05-26T00:01:29.968581+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CFO Franco Valle resigns effective March 7, 2025; no replacement named.

## Summary
- Franco Valle resigned as CFO, effective March 7, 2025.
- No disagreements between Valle and the Company were cited.
- Departure is unrelated to any financial or accounting operations.
- No successor has been announced as of the filing date.

## SEC filing metadata
- accession: 0001193125-25-042468
- form_type: 8-K
- ticker: BMEA
- cik: 0001840439
- company_name: Biomea Fusion, Inc.
- filed_at: 2025-02-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840439/000119312525042468/0001193125-25-042468-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840439/000119312525042468/d893104d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-042468
- JSON: https://secwatch.observer/filing/0001193125-25-042468.json
- Plain text: https://secwatch.observer/filing/0001193125-25-042468.txt

## Key facts
- Executive change
  Franco Valle resigned as Chief Financial Officer at Biomea Fusion, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On February 24, 2025, Franco Valle resigned as the Chief Financial Officer (principal financial officer and principal accounting officer) of Biomea Fusion, Inc. (the “Company”), effective March 7, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840439/000119312525042468/0001193125-25-042468-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.